Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
20 Results for "
human LILRB4
" in MedChemExpress (MCE) Product Catalog:
Products (20)
20 Results for "human LILRB4" in MCE Product Catalog:
Cat. No.: HY-RS07654
Target:
Research Areas:
LILRB4 Human Pre-designed siRNA Set A contains three designed siRNAs for LILRB4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P991307
Target:
Research Areas:
Cat. No.: HY-P991308
Target:
Cat. No.: HY-184688
CAS No.: 1311612-43-7
ORS-22 is an immunomodulator with a Kd value of 9.2 nM for human LILRB4. ORS-22 binds directly to the extracellular domain of LILRB4, reverses immunosuppression, restores cytotoxic T cell function, recovers cytokine production, and reduces tumor cell viability. ORS-22 can be used in research related to colorectal cancer and acute myeloid leukemia .
Cat. No.: HY-184689
CAS No.: 1311892-52-0
ORS-14 is a LILRB4/ILT3 ligand with a Kd of 85.2 nM for human receptors. ORS-14 blocks SCG2-mediated LILRB4 signaling pathway, reverses SCG2-mediated immunosuppression, restores cytokine production, reduces tumor cell viability, recovers cytotoxic T cell function, and increases the frequency of granzyme B + CD8 + T cells. ORS-14 can be used in research related to colorectal cancer and acute myeloid leukemia .
Cat. No.: HY-184157
Research Areas:
IB15C is an ILT3 (LILRB4) inhibitor with a human Kd of 0.92 μM. IB15C binds to a specific ILT3 pocket, disrupts ApoE interaction, and interferes with downstream inhibitory signaling pathways. IB15C reduces SHP1 and SHP2 phosphorylation, suppresses pro-inflammatory cytokine secretion, enhances amyloid uptake, and attenuates NF-κB activation. IB15C can be used for the research of alzheimer's disease .
Cat. No.: HY-P704762
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P705056
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P701065
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P700780
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P701064
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P700779
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Cat. No.: HY-P701018
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
